Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-030070
Filing Date
2024-12-23
Accepted
2024-12-23 16:15:32
Documents
1
Period of Report
2024-12-20

Document Format Files

Seq Description Document Type Size
1 form4-12232024_041229.html 4  
1 form4-12232024_041229.xml 4 4022
  Complete submission text file 0001415889-24-030070.txt   5477
Mailing Address 1405 RESEARCH BLVD, SUITE 125 ROCKVILLE MD 20850
Business Address 1405 RESEARCH BLVD, SUITE 125 ROCKVILLE MD 20850 (240) 243-8000
Sensei Biotherapeutics, Inc. (Issuer) CIK: 0001829802 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O SENSEI BIOTHERAPEUTICS, INC. 1405 RESEARCH BLVD, SUITE 125 ROCKVILLE MD 20850
Business Address
Krebs Stephanie (Reporting) CIK: 0001998150 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39980 | Film No.: 241573798